Trump’s ‘Most Favored Nation’ drug pricing push risks undermining pro-life legacy

President Donald Trump’s work to lower prescription drug costs for patients will undoubtedly be one of his most significant legacies. From the legislation he recently signed to increase transparency among pharmacy benefit managers to the historic pricing deals he has negotiated with drug manufacturers, Trump has made more progress on this issue than any of […]